Mark W Sawicki Cryoport, Inc. (CYRX) insider trading activity

Mark W Sawicki is Chief Scientific Officer of Cryoport, Inc.. Currently has a direct ownership of 84,087 shares of CYRX, which is worth approximately $467,523. The most recent transaction as insider was on Mar 24, 2025, when has been sold 1,349 shares (Common Stock) at a price of $6.94 per share, resulting in proceeds of $9,362. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 84.1K

8.58% 3M change

8.58% 12M change

Total Value Held $467,523

Mark W Sawicki Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 24 2025	SELL Open market or private sale	$9,362 $6.94 p/Share	1,349 Reduced 1.58%	84,087 Common Stock
Mar 17 2025	SELL Open market or private sale	$13,158 $6.29 p/Share	2,092 Reduced 2.39%	85,436 Common Stock
Mar 14 2025	BUY Grant, award, or other acquisition	-	9,000 Added 9.32%	87,528 Common Stock
Mar 10 2025	SELL Open market or private sale	$7,725 $4.88 p/Share	1,583 Reduced 1.98%	78,528 Common Stock
Mar 09 2025	BUY Exercise of conversion of derivative security	-	2,667 Added 3.22%	80,111 Common Stock
Mar 25 2024	SELL Open market or private sale	$23,977 $17.54 p/Share	1,367 Reduced 1.73%	77,444 Common Stock
Mar 15 2024	SELL Open market or private sale	$20,244 $15.43 p/Share	1,312 Reduced 1.76%	73,061 Common Stock
Mar 15 2024	BUY Grant, award, or other acquisition	-	5,750 Added 6.8%	78,811 Common Stock
Mar 11 2024	SELL Open market or private sale	$23,184 $16.35 p/Share	1,418 Reduced 1.87%	74,373 Common Stock
Mar 09 2024	BUY Exercise of conversion of derivative security	-	2,666 Added 3.4%	75,791 Common Stock
Sep 12 2023	BUY Exercise of conversion of derivative security	$12,790 $12.79 p/Share	1,000 Added 1.35%	73,125 Common Stock
Mar 22 2023	BUY Grant, award, or other acquisition	-	10,455 Added 12.66%	72,125 Common Stock
Mar 15 2023	SELL Open market or private sale	$28,315 $20.79 p/Share	1,362 Reduced 2.16%	61,670 Common Stock
Mar 13 2023	SELL Open market or private sale	$29,726 $20.14 p/Share	1,476 Reduced 2.29%	63,032 Common Stock
Mar 09 2023	BUY Exercise of conversion of derivative security	-	2,667 Added 3.97%	64,508 Common Stock
Mar 14 2022	BUY Grant, award, or other acquisition	-	10,455 Added 14.46%	61,841 Common Stock
Mar 09 2022	SELL Open market or private sale	$43,780 $31.05 p/Share	1,410 Reduced 2.67%	51,386 Common Stock
Mar 09 2022	BUY Exercise of conversion of derivative security	-	2,667 Added 4.81%	52,796 Common Stock
Aug 11 2021	SELL Open market or private sale	$4,736,628 $59.1 p/Share	80,146 Reduced 61.52%	50,129 Common Stock
Aug 11 2021	BUY Exercise of conversion of derivative security	$775,282 $8.23 p/Share	94,202 Added 41.97%	130,275 Common Stock
Mar 10 2021	SELL Open market or private sale	$733,072 $54.99 p/Share	13,331 Reduced 26.98%	36,073 Common Stock
Mar 10 2021	BUY Exercise of conversion of derivative security	$82,699 $2.72 p/Share	30,404 Added 38.1%	49,404 Common Stock

MWS

Mark W Sawicki

Chief Scientific Officer

Brentwood, TN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYRX shares.

Notify only if

Value

Insider Trading

Get notified when an Cryoport, Inc. insider buys or sells CYRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cryoport, Inc.

Track Activities on CYRX

Account